Kidney Disease

SAN DIEGO — Compared with placebo, finerenone was associated with reductions in albuminuria and decreased risk of new-onset albuminuria among adults with heart failure, according to data from the FINEARTS-HF trial.

SAN DIEGO — In this video exclusive from ASN Kidney Week, Darcy K. Weidemann, MD, MHS, FAAP, a pediatric nephrologist at Children’s Mercy in Kansas City, Missouri, discusses her top concerns in the specialty: access and workforce.

SAN DIEGO — Health care providers and advocates must confront social disparities among patients with kidney disease to improve the standard of care, American Society of Nephrology President Deidra C. Crews, MD, ScM, FASN, said.

Oral semaglutide demonstrated an approximately 14% reduction in major adverse CV events compared with standard care along in patients with diabetes, CVD and/or kidney disease, according to the top-line results of the phase 3 SOUL trial.

The National Kidney Foundation Innovation Fund has invested in health technology company Revalia Bio, according to a press release.

It seems that cyber threats are all around us. The recent breach experienced by Change Healthcare certainly highlighted our vulnerability in nephrology practice.

A palliative care-based decision support intervention may be a beneficial for older adults with kidney disease and an acceptable strategy for nephrologists, qualitative data show.

“The historic underfunding of the ESRD payment system has created disincentives for the development of new drugs, biologicals, devices and innovative treatment options ... ”

There may be a nonlinear connection between platelet count and 30-day in-hospital mortality in patients with end-stage kidney disease in the ICU, according to researchers.

The American Nephrology Nurses Association launched a nephology-focused Fellow of the American Nephrology Nurses Association program, according to an association press release.